SAN DIEGO, Oct. 24, 2019 /PRNewswire/ -- Evofem
Biosciences, Inc. (NASDAQ: EVFM) will hold a webcast and conference
call to discuss the Company's financial results and business
highlights for the third quarter ended September 30, 2019.
Date
|
Thursday November 7,
2019
|
Time
|
11:00 a.m. EST (8:00
a.m. PST)
|
Dial-in
numbers
|
(866) 503-5561 (U.S.
toll-free) or (253) 336-2965
|
Passcode
|
3857878
|
Webcast (live and
archived)
|
www.evofem.com under
"Investors" or click here
|
The live webcast and related slide presentation can be accessed
on the Company's Investor page at
https://evofem.investorroom.com/events. Please connect to the
Company's website at least 15 minutes prior to the start of the
call to download any software that may be required. If
participating by phone, please dial in approximately 10 minutes
prior to the start of the call.
A telephone replay will be available approximately two hours
after the call through Tuesday, November 12, 2019
at (855) 859-2056 (U.S.) or (404) 537-3406
(International), access code 3857878. The webcast will be archived
at https://evofem.investorroom.com/events.
About Evofem Biosciences
Evofem Biosciences, Inc. is a
clinical-stage biopharmaceutical company committed to developing
and commercializing innovative products to address unmet needs in
women's sexual and reproductive health. Evofem Biosciences aims to
advance the lives of women by developing novel solutions, such as
woman-controlled contraception and potential protection from
certain sexually transmitted infections. The Company is
leveraging its proprietary Multipurpose Vaginal pH Regulator
(MVP-R™) platform to develop Amphora® (L-lactic acid, citric acid
and potassium bitartrate) for hormone-free birth control and
prevention of chlamydia. For more information, please visit
www.evofem.com.
Amphora® is a registered trademark and MVP-R™ is a
trademark of Evofem Biosciences, Inc.
Investor Contact
Amy
Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
M: (917) 673-5775
Media Contact
Cara
Miller
Evofem Biosciences, Inc.
cmiller@evofem.com
O: (858) 550-1900 x272
View original content to download
multimedia:http://www.prnewswire.com/news-releases/evofem-biosciences-to-report-third-quarter-2019-results-and-provide-corporate-update-on-november-7-2019-300944544.html
SOURCE Evofem Biosciences, Inc.